Type 2 diabetes
Conditions
Interventions
None listed
Sponsors
Hokkaido University Hospital
Department of Pathology and Molecular Medicine, Hirosaki University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Agreement to participate to this study
Exclusion criteria
Exclusion criteria: Participants who thought to be inappropriate to enter this study for some reasons by physician's judgments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of PFKFB3-positive beta cell ratio between non-diabetics and patients with type 2 diabetes | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) PFKFB3-positive beta cell ratio in patients with impaired glucose tolerance 2) Relationship between PFKFB3-positive beta cell ratio and patients' background characteristics 3) Association between PFKFB3-positive beta cell ratio and islet amyloid deposition 4) Comparison of PFKFB3 expression intensity in beta cells among non-diabetics, patients with impaired glucose tolerance and those with type 2 diabetes | — |
Countries
Japan
Contacts
Public ContactNomoto Hiroshi
Hokkaido University Hospital Department of Internal Medicine II
Outcome results
None listed